Free Trial

Brokers Offer Predictions for Vital Farms Q2 Earnings

Vital Farms logo with Consumer Staples background

Vital Farms, Inc. (NASDAQ:VITL - Free Report) - Investment analysts at Telsey Advisory Group decreased their Q2 2025 earnings per share estimates for shares of Vital Farms in a research note issued to investors on Friday, May 9th. Telsey Advisory Group analyst S. Vora now expects that the company will earn $0.27 per share for the quarter, down from their prior estimate of $0.28. Telsey Advisory Group currently has a "Outperform" rating and a $52.00 target price on the stock. The consensus estimate for Vital Farms' current full-year earnings is $1.11 per share. Telsey Advisory Group also issued estimates for Vital Farms' Q4 2025 earnings at $0.36 EPS, FY2025 earnings at $1.26 EPS and FY2026 earnings at $1.52 EPS.

Vital Farms (NASDAQ:VITL - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.37 EPS for the quarter, beating analysts' consensus estimates of $0.26 by $0.11. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The company had revenue of $162.19 million during the quarter, compared to analysts' expectations of $164.43 million. During the same period in the prior year, the company earned $0.43 EPS. Vital Farms's revenue was up 9.7% compared to the same quarter last year.

A number of other analysts also recently weighed in on VITL. Stifel Nicolaus upgraded Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price objective for the company in a report on Friday, February 28th. Morgan Stanley decreased their price objective on Vital Farms from $40.00 to $39.00 and set an "overweight" rating for the company in a report on Thursday, April 17th. William Blair restated an "outperform" rating on shares of Vital Farms in a report on Friday, February 28th. DA Davidson decreased their price objective on Vital Farms from $44.00 to $42.00 and set a "buy" rating for the company in a report on Friday, March 14th. Finally, BMO Capital Markets upgraded Vital Farms to a "strong-buy" rating in a report on Tuesday, May 6th. Eight investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $44.63.

Read Our Latest Analysis on Vital Farms

Vital Farms Stock Performance

NASDAQ VITL opened at $33.82 on Monday. The company has a market capitalization of $1.51 billion, a price-to-earnings ratio of 30.20 and a beta of 0.94. Vital Farms has a twelve month low of $27.91 and a twelve month high of $48.41. The stock has a fifty day simple moving average of $32.50 and a 200 day simple moving average of $35.07. The company has a quick ratio of 2.81, a current ratio of 3.24 and a debt-to-equity ratio of 0.04.

Insiders Place Their Bets

In other Vital Farms news, CEO Russell Diez-Canseco sold 45,124 shares of the stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $33.69, for a total transaction of $1,520,227.56. Following the completion of the sale, the chief executive officer now directly owns 703,736 shares in the company, valued at approximately $23,708,865.84. This trade represents a 6.03% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Matthew Ohayer sold 4,000 shares of the stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $31.39, for a total value of $125,560.00. Following the sale, the insider now owns 6,966,890 shares of the company's stock, valued at approximately $218,690,677.10. The trade was a 0.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 93,124 shares of company stock worth $3,019,308. Company insiders own 27.60% of the company's stock.

Institutional Trading of Vital Farms

A number of large investors have recently bought and sold shares of the business. Blair William & Co. IL grew its stake in shares of Vital Farms by 180.2% in the 1st quarter. Blair William & Co. IL now owns 31,820 shares of the company's stock valued at $970,000 after buying an additional 20,463 shares during the period. Jupiter Asset Management Ltd. increased its position in Vital Farms by 20.0% in the 1st quarter. Jupiter Asset Management Ltd. now owns 754,283 shares of the company's stock valued at $22,983,000 after buying an additional 125,574 shares in the last quarter. Alberta Investment Management Corp bought a new stake in Vital Farms in the 1st quarter valued at about $1,026,000. US Bancorp DE increased its position in Vital Farms by 36.2% in the 1st quarter. US Bancorp DE now owns 1,929 shares of the company's stock valued at $59,000 after buying an additional 513 shares in the last quarter. Finally, Vestcor Inc increased its position in Vital Farms by 20.2% in the 1st quarter. Vestcor Inc now owns 29,064 shares of the company's stock valued at $886,000 after buying an additional 4,875 shares in the last quarter. 98.59% of the stock is currently owned by institutional investors and hedge funds.

About Vital Farms

(Get Free Report)

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

Read More

Earnings History and Estimates for Vital Farms (NASDAQ:VITL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vital Farms Right Now?

Before you consider Vital Farms, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.

While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines